Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects

BACKGROUND: The linkage between IDO2 expression and cancer progression is still unclear, particularly in medullary thyroid carcinoma (MTC). Our purpose is to unveil the potential correlations between IDO2 status, clinical-pathological parameters, patients’ prognosis, and the possible immunomodulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Pengfei, Ling, Bin, Ma, Weike, Zhang, Jinming, Zhang, Wei, Zeng, Yu, Liu, Yu, Chi, Jiadong, Ruan, Xianhui, Zheng, Xiangqian, Wei, Songfeng, Gao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624013/
https://www.ncbi.nlm.nih.gov/pubmed/36319978
http://dx.doi.org/10.1186/s12885-022-10173-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624013/
https://www.ncbi.nlm.nih.gov/pubmed/36319978
http://dx.doi.org/10.1186/s12885-022-10173-7

Ejemplares similares